ASCO GU 2021 Penile, Urethral, Testicular, and Adrenal Cancers

Viewing 1-13 of 13 articles

ASCO GU 2021: Australia and New Zealand Outcomes of High-Dose Chemotherapy and Stem Cell Transplantation for Relapsed or Refractory Germ Cell Tumors from 1999 to 2019: Multicenter Registry-Based Study with ABMTRR

ASCO GU 2021: Longer Follow-up Data of Circulating miR371a-3p Expression Across the Spectrum of Germ Cell Tumors

ASCO GU 2021: Prediction Model for Brain Metastasis in Patients with Metastatic Germ-Cell Tumors Accounting for Size of Pulmonary Metastases

ASCO GU 2021: Discussant: Results from the TRISST and SEMS Trials

ASCO GU 2021: Comprehensive Genomic Profiling in Patients with Relapsed/Refractory Germ Cell Tumors

ASCO GU 2021: Pre-Orchiectomy Serum Tumor Markers as a Predictor of Recurrence in Stage I Germ Cell Tumors

ASCO GU 2021: Paclitaxel, Ifosfamide & Cisplatin (TIP) as Second-Line Therapy for Germ Cell Tumors: Long-Term Follow-up and Expansion Cohort

ASCO GU 2021: Surgery In Early Metastatic Seminoma, The Phase II SEMS Trial

ASCO GU 2021: TRISST: Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results from a Randomized, Phase III, Factorial Trial

ASCO GU 2021: Invited Discussion: Testicular Seminoma

ASCO GU 2021: Imaging Modality And Frequency In Surveillance of Stage I Seminoma Testicular Cancer: Results From A Randomized, Phase III, Factorial Trial (TRISST)

ASCO GU 2021: SEMS trial: Result of a Prospective, Multi-Institutional Phase II Clinical Trial of Surgery In Early Metastatic Seminoma

ASCO GU 2021: An Open-Label, Multicenter, Phase IIIb Study of Patients With Urinary Tract Carcinoma (STRONG): Final Analysis for Fixed-Dose Durvalumab Monotherapy (Module A)

email news signup